Bioextrax AB (publ) (STO:BIOEX)
Sweden
· Delayed Price · Currency is SEK 2.730
-0.010 (-0.36%)
Mar 9, 2026, 5:13 PM CET
Bioextrax AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 0.76 | 0.52 | 2.06 | 0.4 | 0.28 | Upgrade
|
| Other Revenue | 0.55 | 0.5 | 0.95 | 1.8 | 0.75 | Upgrade
|
| Revenue | 1.31 | 1.01 | 3.01 | 2.2 | 1.03 | Upgrade
|
| Revenue Growth (YoY) | 29.48% | -66.38% | 36.81% | 113.61% | 363.98% | Upgrade
|
| Cost of Revenue | 1.26 | 1.43 | 1.34 | 1.35 | 1.03 | Upgrade
|
| Gross Profit | 0.05 | -0.42 | 1.67 | 0.85 | -0 | Upgrade
|
| Selling, General & Admin | 16.74 | 16.04 | 22.37 | 19.19 | 10.18 | Upgrade
|
| Other Operating Expenses | 0.02 | -0.08 | 0.04 | -0.15 | -0 | Upgrade
|
| Operating Expenses | 17.89 | 17.12 | 23.27 | 19.52 | 10.53 | Upgrade
|
| Operating Income | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 | Upgrade
|
| Interest Expense | -0 | -0 | - | - | -0 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.2 | 0.09 | - | - | Upgrade
|
| Pretax Income | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 | Upgrade
|
| Net Income | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 | Upgrade
|
| Net Income to Common | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 33 | 27 | 17 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 33 | 27 | 17 | 13 | Upgrade
|
| Shares Change (YoY) | 18.85% | 25.69% | 56.94% | 26.08% | 13.76% | Upgrade
|
| EPS (Basic) | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 | Upgrade
|
| EPS (Diluted) | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 | Upgrade
|
| Free Cash Flow | -26.2 | -18.99 | -24.41 | -24.38 | -9.45 | Upgrade
|
| Free Cash Flow Per Share | -0.66 | -0.57 | -0.92 | -1.44 | -0.70 | Upgrade
|
| Gross Margin | 3.90% | -41.44% | 55.50% | 38.81% | -0.39% | Upgrade
|
| Operating Margin | -1362.80% | -1734.82% | -718.29% | -849.27% | -1023.23% | Upgrade
|
| Profit Margin | -1352.56% | -1714.94% | -715.23% | -849.27% | -1023.52% | Upgrade
|
| Free Cash Flow Margin | -2001.38% | -1878.63% | -811.77% | -1109.19% | -918.56% | Upgrade
|
| EBITDA | -16.71 | -16.38 | -20.74 | -18.19 | -10.18 | Upgrade
|
| D&A For EBITDA | 1.13 | 1.16 | 0.86 | 0.48 | 0.35 | Upgrade
|
| EBIT | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 | Upgrade
|
| Revenue as Reported | 1.31 | 1.01 | 3.01 | 2.23 | 1.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.